KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Deferred Taxes (2016 - 2025)

Merck (MRK) has disclosed Deferred Taxes for 17 consecutive years, with -$825.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Deferred Taxes fell 33.93% to -$825.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.7 billion, a 33.79% decrease, with the full-year FY2025 number at -$1.7 billion, down 33.79% from a year prior.
  • Deferred Taxes was -$825.0 million for Q4 2025 at Merck, down from -$212.0 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $159.0 million in Q4 2021 to a low of -$931.0 million in Q4 2023.
  • A 5-year average of -$310.0 million and a median of -$292.0 million in 2022 define the central range for Deferred Taxes.
  • Peak YoY movement for Deferred Taxes: skyrocketed 126.59% in 2021, then tumbled 66000.0% in 2022.
  • Merck's Deferred Taxes stood at $159.0 million in 2021, then tumbled by 293.08% to -$307.0 million in 2022, then tumbled by 203.26% to -$931.0 million in 2023, then skyrocketed by 33.83% to -$616.0 million in 2024, then tumbled by 33.93% to -$825.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRK's Deferred Taxes are -$825.0 million (Q4 2025), -$212.0 million (Q3 2025), and -$448.0 million (Q2 2025).